Serum- and glucocorticoid-regulated kinase isoform-1 and epithelial sodium channel subunits in human ocular ciliary epithelium

Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1643-51. doi: 10.1167/iovs.02-0514.

Abstract

Purpose: In peripheral sodium-transporting tissues, the serum- and glucocorticoid-regulated kinase (SGK) isoform-1 is an early corticosteroid target gene in the activation of epithelial sodium channels (ENaCs). Sodium transport across the human ocular nonpigmented and pigmented ciliary epithelial bilayer (NPE-PE) is essential for aqueous humor production, but the expression of SGK1 and ENaC subunits remain to be defined.

Methods: SGK1 and ENaC subunits were evaluated by in situ hybridization and RT-PCR analysis on human NPE-PE sections and an NPE cell line (ODM-2). Northern blot analyses were conducted on ODM-2 cells incubated with dexamethasone (DEX) or aldosterone (ALDO) and RU38486 (a glucocorticoid receptor [GR] antagonist) or RU26752 (a mineralocorticoid receptor [MR] antagonist) or both inhibitors. The affinity of the GRs and MRs for DEX and ALDO was assessed by radioligand-binding assays.

Results: Expression of SGK1 and ENaC subunits was confirmed in NPE-PE tissues and ODM-2 cells. Dose-dependent induction of SGK1 mRNA in the ODM-2 cells was demonstrated after incubation with DEX or ALDO. While response to DEX was not inhibited by RU38486 or RU26752, there was a moderate reduction in induction by ALDO in the presence of RU26752 that was completely abolished in the presence of both inhibitors. Specific binding of (3)[H]DEX and (3)[H]ALDO was established, revealing greater expression of GRs than MRs.

Conclusions: The expression of ENaCs within the NPE-PE and corticosteroid regulation of SGK1 through the GR and MR, indicate that this mechanism may be a feature of sodium transport in the human ocular ciliary epithelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone / pharmacology
  • Blotting, Northern
  • Cell Line
  • Ciliary Body / drug effects
  • Ciliary Body / metabolism*
  • Dexamethasone / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Epithelial Sodium Channels
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / pharmacology
  • Hormone Antagonists / pharmacology
  • Humans
  • Immediate-Early Proteins
  • In Situ Hybridization
  • Isoenzymes
  • Mifepristone / pharmacology
  • Mineralocorticoid Receptor Antagonists
  • Nuclear Proteins*
  • Pigment Epithelium of Eye / drug effects
  • Pigment Epithelium of Eye / metabolism*
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Serine-Threonine Kinases / metabolism
  • RNA, Messenger / metabolism
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sodium Channels / genetics*
  • Sodium Channels / metabolism
  • Spironolactone / analogs & derivatives*
  • Spironolactone / pharmacology

Substances

  • Drug Combinations
  • Epithelial Sodium Channels
  • Glucocorticoids
  • Hormone Antagonists
  • Immediate-Early Proteins
  • Isoenzymes
  • Mineralocorticoid Receptor Antagonists
  • Nuclear Proteins
  • RNA, Messenger
  • Receptors, Glucocorticoid
  • Sodium Channels
  • Spironolactone
  • Mifepristone
  • Aldosterone
  • 7-propyl spirolactone
  • Dexamethasone
  • Protein Serine-Threonine Kinases
  • serum-glucocorticoid regulated kinase